Bellevue Group
Latest statistics and disclosures from Bellevue Group's latest quarterly 13F-HR filing:
- Top 5 stock holdings are IONS, ARGX, NBIX, VRTX, MRNA, and represent 21.83% of Bellevue Group's stock portfolio.
- Added to shares of these 10 stocks: INCY (+$17M), ISRG (+$16M), DXCM (+$15M), CNC (+$14M), ABT (+$13M), FATE (+$11M), MGNX (+$11M), OM (+$11M), HCA (+$11M), IONS (+$11M).
- Started 8 new stock positions in RCKT, NTRA, ISEE, NVCR, KRTX, ARWR, ALKS, BLU.
- Reduced shares in these 10 stocks: Abiomed (-$41M), UNH (-$38M), HZNP (-$33M), ELV (-$27M), MOH (-$18M), VRTX (-$18M), AXNX (-$18M), LEGN (-$14M), HUM (-$12M), JAZZ (-$11M).
- Sold out of its positions in Abiomed, Avalara, CRBU, CTLT, NVST, NTLA, EL, NPCE, LUNG, RLMD. RGEN, SWKS, ZTS.
- Bellevue Group was a net seller of stock by $-9.3M.
- Bellevue Group has $7.5B in assets under management (AUM), dropping by 8.14%.
- Central Index Key (CIK): 0001674546
Tip: Access up to 7 years of quarterly data
Positions held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data
Download as csv

Portfolio Holdings for Bellevue Group
Bellevue Group holds 171 positions in its portfolio as reported in the December 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Ionis Pharmaceuticals (IONS) | 4.9 | $368M | +2% | 9.7M | 37.77 |
|
Argenx Se Sponsored Adr (ARGX) | 4.6 | $345M | 911k | 378.83 |
|
|
Neurocrine Biosciences (NBIX) | 4.4 | $331M | -2% | 2.8M | 119.44 |
|
Vertex Pharmaceuticals Incorporated (VRTX) | 4.2 | $317M | -5% | 1.1M | 288.78 |
|
Moderna (MRNA) | 3.8 | $284M | 1.6M | 179.62 |
|
|
Intuitive Surgical Com New (ISRG) | 3.4 | $254M | +6% | 957k | 265.35 |
|
Incyte Corporation (INCY) | 3.2 | $238M | +7% | 3.0M | 80.32 |
|
Alnylam Pharmaceuticals (ALNY) | 2.9 | $219M | -3% | 921k | 237.65 |
|
Abbott Laboratories (ABT) | 2.5 | $185M | +7% | 1.7M | 109.79 |
|
Boston Scientific Corporation (BSX) | 2.4 | $181M | +2% | 3.9M | 46.27 |
|
Intra Cellular Therapies (ITCI) | 2.3 | $177M | 3.3M | 52.92 |
|
|
Myovant Sciences | 2.1 | $159M | 5.9M | 26.96 |
|
|
Jazz Pharmaceuticals Shs Usd (JAZZ) | 1.6 | $121M | -8% | 757k | 159.31 |
|
Stryker Corporation (SYK) | 1.6 | $120M | +3% | 492k | 244.49 |
|
Axonics Modulation Technolog (AXNX) | 1.6 | $119M | -13% | 1.9M | 62.53 |
|
UnitedHealth (UNH) | 1.6 | $119M | -24% | 224k | 530.18 |
|
Revolution Medicines (RVMD) | 1.5 | $116M | +3% | 4.9M | 23.82 |
|
Agios Pharmaceuticals (AGIO) | 1.5 | $114M | 4.1M | 28.08 |
|
|
Sage Therapeutics (SAGE) | 1.5 | $113M | 3.0M | 38.14 |
|
|
Dex (DXCM) | 1.5 | $112M | +14% | 989k | 113.24 |
|
Insulet Corporation (PODD) | 1.4 | $102M | -7% | 346k | 294.39 |
|
Inspire Med Sys (INSP) | 1.3 | $101M | 402k | 251.88 |
|
|
Danaher Corporation (DHR) | 1.3 | $97M | 366k | 265.42 |
|
|
Sarepta Therapeutics (SRPT) | 1.2 | $90M | -8% | 693k | 129.58 |
|
Becton, Dickinson and (BDX) | 1.1 | $84M | 332k | 254.30 |
|
|
Tandem Diabetes Care Com New (TNDM) | 1.1 | $81M | +14% | 1.8M | 44.95 |
|
Celldex Therapeutics Com New (CLDX) | 1.1 | $80M | 1.8M | 44.57 |
|
|
Hca Holdings (HCA) | 1.1 | $80M | +15% | 331k | 239.96 |
|
Edwards Lifesciences (EW) | 1.1 | $79M | +3% | 1.1M | 74.61 |
|
Anthem (ELV) | 1.0 | $77M | -26% | 149k | 512.97 |
|
Arvinas Ord (ARVN) | 1.0 | $74M | 2.2M | 34.21 |
|
|
Outset Med (OM) | 1.0 | $73M | +17% | 2.8M | 25.82 |
|
Option Care Health Com New (OPCH) | 1.0 | $73M | -7% | 2.4M | 30.09 |
|
Insmed Com Par $.01 (INSM) | 0.9 | $66M | 3.3M | 19.98 |
|
|
EXACT Sciences Corporation (EXAS) | 0.9 | $65M | +16% | 1.3M | 49.51 |
|
Charles River Laboratories (CRL) | 0.8 | $63M | +10% | 290k | 217.90 |
|
Relay Therapeutics (RLAY) | 0.8 | $63M | 4.2M | 14.94 |
|
|
Molina Healthcare (MOH) | 0.8 | $61M | -22% | 186k | 330.22 |
|
Macrogenics (MGNX) | 0.8 | $60M | +22% | 9.0M | 6.71 |
|
Apellis Pharmaceuticals (APLS) | 0.8 | $57M | +9% | 1.1M | 51.71 |
|
Centene Corporation (CNC) | 0.8 | $57M | +31% | 694k | 82.01 |
|
Humana (HUM) | 0.8 | $57M | -17% | 111k | 512.19 |
|
Evolent Health Cl A (EVH) | 0.7 | $56M | +6% | 2.0M | 28.08 |
|
Silk Road Medical Inc Common (SILK) | 0.7 | $54M | -3% | 1.0M | 52.85 |
|
Pacific Biosciences of California (PACB) | 0.7 | $53M | +19% | 6.5M | 8.18 |
|
Cigna Corp (CI) | 0.7 | $53M | -15% | 159k | 331.34 |
|
Amedisys (AMED) | 0.7 | $51M | +2% | 614k | 83.54 |
|
Shockwave Med (SWAV) | 0.7 | $51M | -10% | 248k | 205.61 |
|
Globus Med Cl A (GMED) | 0.7 | $51M | +5% | 680k | 74.27 |
|
Penumbra (PEN) | 0.7 | $50M | +18% | 226k | 222.46 |
|
Fate Therapeutics (FATE) | 0.7 | $49M | +29% | 4.9M | 10.09 |
|
Medtronic SHS (MDT) | 0.6 | $48M | 618k | 77.72 |
|
|
Bio Rad Labs Cl A (BIO) | 0.6 | $47M | +9% | 111k | 420.49 |
|
Halozyme Therapeutics (HALO) | 0.6 | $46M | -12% | 813k | 56.90 |
|
Thermo Fisher Scientific (TMO) | 0.6 | $46M | +15% | 83k | 550.69 |
|
IDEXX Laboratories (IDXX) | 0.6 | $44M | 109k | 407.96 |
|
|
Exelixis (EXEL) | 0.6 | $43M | 2.7M | 16.04 |
|
|
Transmedics Group (TMDX) | 0.6 | $42M | +4% | 682k | 61.72 |
|
Pfizer (PFE) | 0.5 | $40M | +2% | 789k | 51.24 |
|
Iqvia Holdings (IQV) | 0.5 | $38M | +14% | 183k | 204.89 |
|
Crispr Therapeutics Namen Akt (CRSP) | 0.5 | $37M | 912k | 40.65 |
|
|
Caredx (CDNA) | 0.5 | $36M | +21% | 3.2M | 11.41 |
|
Zimmer Holdings (ZBH) | 0.5 | $34M | 266k | 127.50 |
|
|
Axsome Therapeutics (AXSM) | 0.4 | $34M | -12% | 437k | 77.13 |
|
Biontech Se Sponsored Ads (BNTX) | 0.4 | $33M | +43% | 221k | 150.22 |
|
Harmony Biosciences Hldgs In (HRMY) | 0.4 | $33M | -9% | 596k | 55.10 |
|
Wave Life Sciences SHS (WVE) | 0.4 | $32M | 4.5M | 7.00 |
|
|
Procept Biorobotics Corp (PRCT) | 0.4 | $31M | +25% | 742k | 41.54 |
|
Veeva Sys Cl A Com (VEEV) | 0.4 | $30M | +18% | 186k | 161.38 |
|
Accolade (ACCD) | 0.4 | $29M | +2% | 3.7M | 7.79 |
|
AtriCure (ATRC) | 0.4 | $29M | 644k | 44.38 |
|
|
Hutchmed China Sponsored Ads (HCM) | 0.4 | $28M | 1.8M | 15.97 |
|
|
Beam Therapeutics (BEAM) | 0.4 | $27M | +21% | 697k | 39.11 |
|
Esperion Therapeutics (ESPR) | 0.4 | $27M | +2% | 4.3M | 6.23 |
|
Cooper Cos Com New (COO) | 0.4 | $27M | 81k | 330.67 |
|
|
Omnicell (OMCL) | 0.3 | $26M | +25% | 518k | 50.42 |
|
Mersana Therapeutics (MRSN) | 0.3 | $25M | +4% | 4.3M | 5.86 |
|
Adaptive Biotechnologies Cor (ADPT) | 0.3 | $23M | -9% | 3.0M | 7.64 |
|
Castle Biosciences (CSTL) | 0.3 | $22M | 944k | 23.54 |
|
|
Phreesia (PHR) | 0.3 | $22M | 666k | 32.36 |
|
|
Kezar Life Sciences (KZR) | 0.3 | $21M | 3.0M | 7.04 |
|
|
Privia Health Group (PRVA) | 0.3 | $21M | +74% | 901k | 22.71 |
|
ResMed (RMD) | 0.3 | $21M | +16% | 98k | 208.13 |
|
Essa Pharma Com New (EPIX) | 0.3 | $20M | +33% | 7.9M | 2.52 |
|
Scholar Rock Hldg Corp (SRRK) | 0.3 | $20M | 2.2M | 9.05 |
|
|
Illumina (ILMN) | 0.3 | $19M | +10% | 95k | 202.20 |
|
CVS Caremark Corporation (CVS) | 0.3 | $19M | -9% | 204k | 93.19 |
|
Hologic (HOLX) | 0.2 | $18M | -3% | 243k | 74.81 |
|
Legend Biotech Corp Sponsored Ads (LEGN) | 0.2 | $18M | -43% | 355k | 49.92 |
|
Align Technology (ALGN) | 0.2 | $17M | +5% | 79k | 210.90 |
|
Baxter International (BAX) | 0.2 | $16M | 321k | 50.97 |
|
|
Doximity Cl A (DOCS) | 0.2 | $15M | +131% | 449k | 33.56 |
|
Generation Bio (GBIO) | 0.2 | $14M | 3.6M | 3.93 |
|
|
10x Genomics Cl A Com (TXG) | 0.2 | $12M | +27% | 325k | 36.44 |
|
Regeneron Pharmaceuticals (REGN) | 0.2 | $11M | -9% | 16k | 721.49 |
|
Gilead Sciences (GILD) | 0.1 | $11M | +33% | 130k | 85.85 |
|
Nevro (NVRO) | 0.1 | $10M | 261k | 39.60 |
|
|
Amgen (AMGN) | 0.1 | $10M | -13% | 39k | 262.64 |
|
Avantor (AVTR) | 0.1 | $9.9M | -6% | 472k | 21.09 |
|
Black Diamond Therapeutics (BDTX) | 0.1 | $9.7M | +14% | 5.4M | 1.80 |
|
Teladoc (TDOC) | 0.1 | $9.2M | 390k | 23.65 |
|
|
Biogen Idec (BIIB) | 0.1 | $7.9M | 28k | 276.92 |
|
|
Beigene Sponsored Adr (BGNE) | 0.1 | $7.7M | +392% | 35k | 223.62 |
|
Natera (NTRA) | 0.1 | $7.0M | NEW | 174k | 40.17 |
|
Dr Reddys Labs Adr (RDY) | 0.1 | $6.4M | +912% | 126k | 51.24 |
|
Olink Hldg Ab Sponsored Ads (OLK) | 0.1 | $6.4M | +8% | 251k | 25.38 |
|
BioMarin Pharmaceutical (BMRN) | 0.1 | $6.3M | +13% | 61k | 103.49 |
|
Teleflex Incorporated (TFX) | 0.1 | $6.3M | -20% | 25k | 249.63 |
|
Aurinia Pharmaceuticals (AUPH) | 0.1 | $5.6M | -54% | 1.3M | 4.32 |
|
American Well Corp Cl A (AMWL) | 0.1 | $5.5M | +10% | 2.0M | 2.83 |
|
Astrazeneca Sponsored Adr (AZN) | 0.1 | $4.6M | +54% | 69k | 67.86 |
|
Johnson & Johnson (JNJ) | 0.1 | $4.6M | -15% | 26k | 176.65 |
|
Eli Lilly & Co. (LLY) | 0.1 | $4.0M | +16% | 11k | 365.84 |
|
Supernus Pharmaceuticals (SUPN) | 0.1 | $4.0M | -6% | 111k | 35.67 |
|
Molecular Templates (MTEM) | 0.0 | $3.7M | 11M | 0.33 |
|
|
Guardant Health (GH) | 0.0 | $3.7M | +118% | 136k | 27.20 |
|
Bristol Myers Squibb (BMY) | 0.0 | $3.6M | +611% | 50k | 71.95 |
|
Sight Sciences (SGHT) | 0.0 | $3.6M | 295k | 12.21 |
|
|
Seagen (SGEN) | 0.0 | $2.9M | -47% | 23k | 128.51 |
|
Zai Lab Adr (ZLAB) | 0.0 | $2.8M | +145% | 90k | 31.53 |
|
Abbvie (ABBV) | 0.0 | $2.6M | -4% | 16k | 161.61 |
|
Cytokinetics Com New (CYTK) | 0.0 | $2.5M | -23% | 54k | 45.82 |
|
Akero Therapeutics (AKRO) | 0.0 | $2.3M | +2% | 43k | 54.80 |
|
Bicycle Therapeutics Sponsored Ads (BCYC) | 0.0 | $2.1M | -28% | 70k | 29.60 |
|
Homology Medicines (FIXX) | 0.0 | $2.0M | 1.6M | 1.26 |
|
|
Kosmos Energy (KOS) | 0.0 | $2.0M | 318k | 6.36 |
|
|
AmerisourceBergen (ABC) | 0.0 | $1.7M | -14% | 10k | 165.71 |
|
Alkermes SHS (ALKS) | 0.0 | $1.6M | NEW | 36k | 44.53 |
|
Krystal Biotech (KRYS) | 0.0 | $1.4M | 18k | 79.22 |
|
|
Karuna Therapeutics Ord (KRTX) | 0.0 | $1.4M | NEW | 7.3k | 196.50 |
|
Horizon Therapeutics Pub L SHS (HZNP) | 0.0 | $1.4M | -95% | 12k | 113.80 |
|
Arcus Biosciences Incorporated (RCUS) | 0.0 | $1.4M | -21% | 66k | 20.68 |
|
Miragen Therapeutics (VRDN) | 0.0 | $1.3M | 46k | 29.21 |
|
|
Agilent Technologies Inc C ommon (A) | 0.0 | $1.2M | -7% | 8.0k | 149.65 |
|
McKesson Corporation (MCK) | 0.0 | $1.1M | 2.9k | 375.12 |
|
|
Berkeley Lts (CELL) | 0.0 | $1.0M | 385k | 2.68 |
|
|
Iveric Bio (ISEE) | 0.0 | $895k | NEW | 42k | 21.41 |
|
Arrowhead Pharmaceuticals (ARWR) | 0.0 | $864k | NEW | 21k | 40.56 |
|
Denali Therapeutics (DNLI) | 0.0 | $862k | 31k | 27.81 |
|
|
Cardinal Health (CAH) | 0.0 | $815k | +1054% | 11k | 76.87 |
|
Seer Com Cl A (SEER) | 0.0 | $790k | 136k | 5.80 |
|
|
Laboratory Corp Amer Hldgs Com New (LH) | 0.0 | $784k | -14% | 3.3k | 235.48 |
|
Merck & Co (MRK) | 0.0 | $749k | +39% | 6.8k | 110.95 |
|
Inhibrx (INBX) | 0.0 | $732k | -31% | 30k | 24.64 |
|
Rocket Pharmaceuticals (RCKT) | 0.0 | $716k | NEW | 37k | 19.57 |
|
Merus N V (MRUS) | 0.0 | $707k | +79% | 46k | 15.47 |
|
Spdr S&p 500 Etf Tr Tr Unit (SPY) | 0.0 | $688k | 1.8k | 382.43 |
|
|
Xencor (XNCR) | 0.0 | $661k | 25k | 26.04 |
|
|
Novocure Ord Shs (NVCR) | 0.0 | $660k | NEW | 9.0k | 73.33 |
|
Alphabet Cap Stk Cl C (GOOG) | 0.0 | $532k | 6.0k | 88.73 |
|
|
Spdr Ser Tr S&p Oilgas Exp (XOP) | 0.0 | $530k | 3.9k | 135.88 |
|
|
Vaneck Etf Trust Gold Miners Etf (GDX) | 0.0 | $527k | +37% | 18k | 28.66 |
|
Bellus Health Com New (BLU) | 0.0 | $369k | NEW | 45k | 8.22 |
|
Design Therapeutics (DSGN) | 0.0 | $358k | 35k | 10.26 |
|
|
Opthea Sponsored Ads (OPT) | 0.0 | $235k | 47k | 4.99 |
|
|
Ishares Tr Msci China Etf (MCHI) | 0.0 | $195k | 4.1k | 47.50 |
|
|
MarketAxess Holdings (MKTX) | 0.0 | $185k | 662.00 | 278.89 |
|
|
Vaneck Etf Trust Junior Gold Mine (GDXJ) | 0.0 | $178k | 5.0k | 35.65 |
|
|
MercadoLibre (MELI) | 0.0 | $144k | 170.00 | 846.24 |
|
|
Dolby Laboratories Com Cl A (DLB) | 0.0 | $113k | 1.6k | 70.54 |
|
|
Acadia Healthcare (ACHC) | 0.0 | $106k | +42% | 1.3k | 82.32 |
|
IPG Photonics Corporation (IPGP) | 0.0 | $99k | 1.1k | 94.67 |
|
|
United Therapeutics Corporation (UTHR) | 0.0 | $59k | -29% | 212.00 | 278.09 |
|
Jumia Technologies Sponsored Ads (JMIA) | 0.0 | $58k | 18k | 3.21 |
|
|
Nektar Therapeutics (NKTR) | 0.0 | $33k | 15k | 2.26 |
|
|
Equinix (EQIX) | 0.0 | $26k | 40.00 | 655.02 |
|
|
Evertec (EVTC) | 0.0 | $24k | 739.00 | 32.38 |
|
|
Infosys Sponsored Adr (INFY) | 0.0 | $21k | 1.1k | 18.24 |
|
|
United Microelectronics Corp Spon Adr New (UMC) | 0.0 | $18k | 2.7k | 6.62 |
|
|
Taiwan Semiconductor Mfg Sponsored Ads (TSM) | 0.0 | $1.2k | 770.00 | 1.62 |
|
|
Grupo Aeroportuario Del Sure Spon Adr Ser B (ASR) | 0.0 | $157.005000 | 135.00 | 1.16 |
|
Past Filings by Bellevue Group
SEC 13F filings are viewable for Bellevue Group going back to 2016
- Bellevue Group 2022 Q4 filed Feb. 14, 2023
- Bellevue Group 2022 Q3 filed Nov. 14, 2022
- Bellevue Group 2022 Q2 filed Aug. 11, 2022
- Bellevue Group 2022 Q1 filed May 13, 2022
- Bellevue Group 2021 Q4 filed Feb. 10, 2022
- Bellevue Group 2021 Q3 filed Nov. 12, 2021
- Bellevue Group 2021 Q2 filed Aug. 12, 2021
- Bellevue Group 2021 Q1 filed May 12, 2021
- Bellevue Group 2020 Q4 filed Feb. 16, 2021
- Bellevue Group 2020 Q3 filed Nov. 16, 2020
- Bellevue Group 2020 Q2 filed Aug. 13, 2020
- Bellevue Group 2020 Q1 filed May 14, 2020
- Bellevue Group 2019 Q4 filed Feb. 14, 2020
- Bellevue Group 2019 Q3 filed Nov. 14, 2019
- Bellevue Group 2019 Q2 filed Aug. 14, 2019
- Bellevue Group 2019 Q1 filed May 15, 2019